189 related articles for article (PubMed ID: 3580873)
1. Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits.
Strausbaugh LJ
Brain Res; 1987 Apr; 409(2):221-6. PubMed ID: 3580873
[TBL] [Abstract][Full Text] [Related]
2. Albumin content in brain and CSF after intracarotid infusion of protamine sulfate: a longitudinal study.
Westergren I; Johansson BB
Exp Neurol; 1990 Feb; 107(2):192-6. PubMed ID: 2303128
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of amino acids in extracellular fluid after opening of the blood-brain barrier by intracarotid infusion of protamine sulfate.
Westergren I; Nyström B; Hamberger A; Nordborg C; Johansson BB
J Neurochem; 1994 Jan; 62(1):159-65. PubMed ID: 8263515
[TBL] [Abstract][Full Text] [Related]
4. Glutamate enhances brain damage and albumin content in cerebrospinal fluid after intracarotid protamine infusion.
Westergren I; Nordborg C; Johansson BB
Acta Neuropathol; 1993; 85(3):285-90. PubMed ID: 8096352
[TBL] [Abstract][Full Text] [Related]
5. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
[TBL] [Abstract][Full Text] [Related]
6. Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: a comparison between protamine, poly-L-lysine and poly-L-arginine.
Westergren I; Johansson BB
Acta Physiol Scand; 1993 Sep; 149(1):99-104. PubMed ID: 8237428
[TBL] [Abstract][Full Text] [Related]
7. Modification of the blood-brain barrier permeability following intracarotid infusion of vinorelbine.
Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
Anticancer Res; 1995; 15(6B):2593-6. PubMed ID: 8669830
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid hypothermic saline infusion: a new method for reversible blood-brain barrier disruption in anesthetized rats.
Oztaş B; Küçük M
Neurosci Lett; 1995 May; 190(3):203-6. PubMed ID: 7637893
[TBL] [Abstract][Full Text] [Related]
9. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
Kozler P; Pokorný J
Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531
[TBL] [Abstract][Full Text] [Related]
10. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate.
Sage MR; Wilcox J; Evill CA; Benness GT
Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497
[TBL] [Abstract][Full Text] [Related]
11. Effects of intracarotid ionic and non-ionic contrast material on the blood-brain barrier in a rabbit model.
Wilcox J; Evill CA; Sage MR
Neuroradiology; 1986; 28(3):271-4. PubMed ID: 3014375
[TBL] [Abstract][Full Text] [Related]
12. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
13. Depressed cardiovascular function and altered platelet kinetics following protamine sulfate reversal of heparin activity.
Wakefield TW; Whitehouse WM; Stanley JC
J Vasc Surg; 1984 Mar; 1(2):346-55. PubMed ID: 6481883
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid (1-42) peptide impairs blood-brain barrier function after intracarotid infusion in rats.
Jancsó G; Domoki F; Sántha P; Varga J; Fischer J; Orosz K; Penke B; Becskei A; Dux M; Tóth L
Neurosci Lett; 1998 Sep; 253(2):139-41. PubMed ID: 9774169
[TBL] [Abstract][Full Text] [Related]
15. Reversible blood-brain barrier dysfunction after intracarotid hyperthermic saline infusion.
Oztaş B; Küçük M
Int J Hyperthermia; 1998; 14(4):395-401. PubMed ID: 9690151
[TBL] [Abstract][Full Text] [Related]
16. Effects of intracarotid ioxaglate on the normal blood-brain barrier. A comparison of two animal models.
Wilcox J; Sage MR
Neuroradiology; 1985; 27(4):342-5. PubMed ID: 4047391
[TBL] [Abstract][Full Text] [Related]
17. Modification of the blood-brain barrier permeability by vinorelbine: effect of intracarotid infusion compared with intravenous infusion.
Mouchard-Delmas C; Gourdier B; Vistelle R; Wiczewski M
Anticancer Drugs; 1996 Feb; 7(2):213-9. PubMed ID: 8740728
[TBL] [Abstract][Full Text] [Related]
18. Effect of intracarotid infusion of etoposide: modification of the permeability of the blood-brain barrier and the blood-tumor barrier in rat brain tumor model.
Maeda Y; Matsumoto K; Mizumatsu S; Tamiya T; Furuta T; Ohmoto T
Acta Med Okayama; 1999 Feb; 53(1):5-11. PubMed ID: 10096732
[TBL] [Abstract][Full Text] [Related]
19. Electroencephalographic consequences of sodium dehydrocholate-induced blood-brain barrier disruption: Part 1. Acute and chronic effects of intracarotid sodium dehydrocholate.
Zappulla RA; Spigelman MK; Omsberg E; Rosen JJ; Malis LI; Holland JF
Neurosurgery; 1985 May; 16(5):630-8. PubMed ID: 4000434
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological reduction of brain edema induced by intracarotid infusion of protamine sulphate: a comparison between a free radical scavenger and an AMPA receptor antagonist.
Johansson BB; Westergren I
Acta Neurochir Suppl (Wien); 1994; 60():128-31. PubMed ID: 7976524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
